OptimizeRx CorporationOPRXNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank74
5Y CAGR-5.4%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-5.4%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 4.14% |
| Q3 2025 | 2.45% |
| Q2 2025 | 2.37% |
| Q1 2025 | -0.90% |
| Q4 2024 | 1.69% |
| Q3 2024 | -5.75% |
| Q2 2024 | -1.72% |
| Q1 2024 | -5.96% |
| Q4 2023 | 2.76% |
| Q3 2023 | 2.39% |
| Q2 2023 | -6.01% |
| Q1 2023 | 2.83% |
| Q4 2022 | -2.13% |
| Q3 2022 | -7.26% |
| Q2 2022 | 6.00% |
| Q1 2022 | -1.58% |
| Q4 2021 | 3.60% |
| Q3 2021 | 0.03% |
| Q2 2021 | -6.00% |
| Q1 2021 | 131.44% |
| Q4 2020 | 5.46% |
| Q3 2020 | 5.62% |
| Q2 2020 | -0.67% |
| Q1 2020 | -3.16% |
| Q4 2019 | 6.04% |
| Q3 2019 | -11.58% |
| Q2 2019 | 104.31% |
| Q1 2019 | 4.77% |
| Q4 2018 | 4.98% |
| Q3 2018 | 1.70% |
| Q2 2018 | 99.20% |
| Q1 2018 | 13.36% |
| Q4 2017 | 2.69% |
| Q3 2017 | -5.41% |
| Q2 2017 | -7.93% |
| Q1 2017 | -9.64% |
| Q4 2016 | -3.78% |
| Q3 2016 | -2.38% |
| Q2 2016 | -4.94% |
| Q1 2016 | -4.43% |